Sage Therapeutics Inc (SAGE)
13.58
-0.42
(-3.00%)
USD |
NASDAQ |
Apr 25, 16:00
13.60
+0.02
(+0.11%)
After-Hours: 20:00
Sage Therapeutics Research and Development Expense (Quarterly): 64.33M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 64.33M |
| September 30, 2023 | 101.92M |
| June 30, 2023 | 97.16M |
| March 31, 2023 | 92.83M |
| December 31, 2022 | 89.30M |
| September 30, 2022 | 81.55M |
| June 30, 2022 | 77.30M |
| March 31, 2022 | 78.02M |
| December 31, 2021 | 75.44M |
| September 30, 2021 | 83.50M |
| June 30, 2021 | 66.17M |
| March 31, 2021 | 58.06M |
| December 31, 2020 | 81.71M |
| September 30, 2020 | 74.08M |
| June 30, 2020 | 73.32M |
| March 31, 2020 | 63.61M |
| December 31, 2019 | 91.25M |
| September 30, 2019 | 102.11M |
| June 30, 2019 | 89.06M |
| March 31, 2019 | 86.40M |
| December 31, 2018 | 88.80M |
| September 30, 2018 | 75.05M |
| Date | Value |
|---|---|
| June 30, 2018 | 68.98M |
| March 31, 2018 | 49.27M |
| December 31, 2017 | 50.89M |
| September 30, 2017 | 58.29M |
| June 30, 2017 | 55.90M |
| March 31, 2017 | 45.20M |
| December 31, 2016 | 42.00M |
| September 30, 2016 | 29.08M |
| June 30, 2016 | 26.10M |
| March 31, 2016 | 23.58M |
| December 31, 2015 | 20.38M |
| September 30, 2015 | 17.48M |
| June 30, 2015 | 18.60M |
| March 31, 2015 | 12.90M |
| December 31, 2014 | 8.945M |
| September 30, 2014 | 6.601M |
| June 30, 2014 | 4.381M |
| March 31, 2014 | 4.173M |
| December 31, 2013 | 4.512M |
| September 30, 2013 | 3.408M |
| June 30, 2013 | 3.854M |
| March 31, 2013 | 2.583M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
58.06M
Minimum
Mar 2021
102.11M
Maximum
Sep 2019
81.09M
Average
81.55M
Median
Sep 2022
Research and Development Expense (Quarterly) Benchmarks
| Biogen Inc | 452.90M |
| Perspective Therapeutics Inc | 6.08M |
| Vanda Pharmaceuticals Inc | 24.34M |
| ADMA Biologics Inc | 0.4455M |
| Finch Therapeutics Group Inc | 0.00 |